Emergent BioSolutions Inc. — Director's Dealing 2015

Nov 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-11-11

Reporting Person: Labinger Barry (EVP, Biosciences Div.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-11	Common Stock	S	6564	$35.51	Disposed	30229	Direct
2015-11-11	Common Stock	M	9373	$28.09	Acquired	39602	Direct
2015-11-11	Common Stock	S	9373	$35.50	Disposed	30229	Direct
2015-11-11	Common Stock	M	10095	$20.94	Acquired	40324	Direct
2015-11-11	Common Stock	S	10095	$35.50	Disposed	30229	Direct
2015-11-12	Common Stock	M	10094	$20.94	Acquired	40323	Direct
2015-11-12	Common Stock	S	10094	$36	Disposed	30229	Direct
2015-11-11	Common Stock	F	1671	$35.88	Disposed	28558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-11	Stock Option	$28.09	M	9373	Disposed	2021-03-10	Common Stock (9373)	Direct
2015-11-11	Stock Option	$20.94	M	10095	Disposed	2020-11-11	Common Stock (10095)	Direct
2015-11-12	Stock Option	$20.94	M	10094	Disposed	2020-11-11	Common Stock (10094)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on March 11, 2014.

F2: Consists of an option granted under the company's stock incentive plan on November 12, 2013.

F3: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50-$35.59, inclusive.